{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:13:29Z","timestamp":1790684009378,"version":"4.1.0"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,7]]},"DOI":"10.7759\/cureus.112233","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T23:21:32Z","timestamp":1783466492000},"source":"Crossref","is-referenced-by-count":1,"title":["Atypical Neuroleptic Malignant Syndrome Without Hyperthermia: A Case Report"],"prefix":"10.7759","author":[{"given":"Abigael K","family":"Osena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Palak A","family":"Fichadia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erick","family":"Melendez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.142.10.1137","article-title":"Neuroleptic malignant syndrome","volume":"142","author":"Levenson JL","year":"1985","unstructured":"Levenson JL. Neuroleptic malignant syndrome. Am J Psychiatry. 1985, 142:1137-45. 10.1176\/ajp.142.10.1137","journal-title":"Am J Psychiatry"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199819010-00006","article-title":"Neuroleptic malignant syndrome. Recognition, prevention and management","volume":"19","author":"Velamoor VR","year":"1998","unstructured":"Velamoor VR. Neuroleptic malignant syndrome. Recognition, prevention and management. Drug Saf. 1998, 19:73-82. 10.2165\/00002018-199819010-00006","journal-title":"Drug Saf"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s12028-015-0162-5","article-title":"Neuroleptic malignant syndrome: complications, outcomes, and mortality","volume":"24","author":"Modi S","year":"2016","unstructured":"Modi S, Dharaiya D, Schultz L, Varelas P. Neuroleptic malignant syndrome: complications, outcomes, and mortality. Neurocrit Care. 2016, 24:97-103. 10.1007\/s12028-015-0162-5","journal-title":"Neurocrit Care"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s40268-014-0078-0","article-title":"Second-generation antipsychotics and neuroleptic malignant syndrome: systematic review and case report analysis","volume":"15","author":"Belvederi Murri 2015","unstructured":"Belvederi Murri 2015. Second-generation antipsychotics and neuroleptic malignant syndrome: systematic review and case report analysis. Drugs R. D. 15:45-62. 10.1007\/s40268-014-0078-0","journal-title":"Drugs R. D"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2021.1957188","article-title":"Atypical neuroleptic malignant syndrome: case reports and diagnostic challenges","volume":"54","author":"Szota AM","year":"2022","unstructured":"Szota AM, Radajewska I, Araszkiewicz AS. Atypical neuroleptic malignant syndrome: case reports and diagnostic challenges. J Psychoactive Drugs. 2022, 54:284-93. 10.1080\/02791072.2021.1957188","journal-title":"J Psychoactive Drugs"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1996.tb09814.x","article-title":"Catatonia. I. Rating scale and standardized examination","volume":"93","author":"Bush G","year":"1996","unstructured":"Bush G, Fink M, Petrides G, Dowling F, Francis A. Catatonia. I. Rating scale and standardized examination. Acta Psychiatr Scand. 1996, 93:129-36. 10.1111\/j.1600-0447.1996.tb09814.x","journal-title":"Acta Psychiatr Scand"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2019.06.009","article-title":"Atypical neuroleptic malignant syndrome: a systematic review of case reports","volume":"60","author":"Singhai K","year":"2019","unstructured":"Singhai K, Kuppili PP, Nebhinani N. Atypical neuroleptic malignant syndrome: a systematic review of case reports. Gen Hosp Psychiatry. 2019, 60:12-9. 10.1016\/j.genhosppsych.2019.06.009","journal-title":"Gen Hosp Psychiatry"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajp.2019.04.007","article-title":"Atypical neuroleptic malignant syndrome - a case report","volume":"43","author":"Vellekkatt F","year":"2019","unstructured":"Vellekkatt F, Kuppili PP, Bharadwaj B, Menon V. Atypical neuroleptic malignant syndrome - a case report. Asian J Psychiatr. 2019, 43:7-8. 10.1016\/j.ajp.2019.04.007","journal-title":"Asian J Psychiatr"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajp.2017.05.004","article-title":"Neuroleptic malignant syndrome: a neuro-psychiatric emergency: recognition, prevention, and management","volume":"29","author":"Velamoor R","year":"2017","unstructured":"Velamoor R. Neuroleptic malignant syndrome: a neuro-psychiatric emergency: recognition, prevention, and management. Asian J Psychiatr. 2017, 29:106-9. 10.1016\/j.ajp.2017.05.004","journal-title":"Asian J Psychiatr"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/485834-atypical-neuroleptic-malignant-syndrome-without-hyperthermia-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T23:21:33Z","timestamp":1783466493000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/485834-atypical-neuroleptic-malignant-syndrome-without-hyperthermia-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":9,"URL":"https:\/\/doi.org\/10.7759\/cureus.112233","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,7]]}}}